The Forecast Just Changed on Altimmune Inc. (NASDAQ:ALT)

The Forecast Just Changed on Altimmune Inc. (NASDAQ:ALT)

SHARE

The Altimmune Inc. (ALT) shares are trading at lower $10.42. The current analyst price target stands at $13.00.

To add more color to this target, the company’s high over the last year is $11.20 and the low is $1.51. Over the last 52 weeks, ALT is down -6.96% while the S&P 500 is up 1.47%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, ALT reported a profit of $9.52 million. Altimmune Inc. also saw revenues increase to $2.21 million. In addition, ALT has free cash flow of -$4.37 million as of 03-2020 The company’s EBITDA came in at -$7.23 million which compares well with its peers.

ALT Return on Equity (ROE) is -46.20%, and its Return on Assets is -39.40%. All told, it is clear that, ALT needs to be on your watchlist.

Find out when ALT reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. ALT has a short ratio of 0.96 and outstanding shares of 15.11M.

Company Outlook

ALT has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 3.48 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -1.53. Altimmune Inc. ALT also noted assets of $54.23 million at the end of the last quarter. Investors should also keep an eye on sector updates as ALT has historically followed its peers on positive news.

All told, Altimmune Inc. ALT has strung together solid data and demonstrated underlying fundamentals. At its current valuation, ALT represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Altimmune Inc. ALT is now commanding a market cap of 181.62M and a float of 10.43M. ALT is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of ALT stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in ALT, either long or short, and we have not been compensated for this article.